Dyrene

Dyrene

SCHEMBL2413603

Clc1nc(Cl)nc(Nc2ccccc2Cl)n1.[H+]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.96
▸ NFKB1 P19838 2/20 0.57
▸ MAPT P10636 5/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MEN1 O00255 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ IGF1R P08069 1/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.48
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ RAD52 P43351 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ ADRA2A P08913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dyrene SCHEMBL6754828 0.98 TSHR (0.92) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL16426463 0.98 TSHR (0.92) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL133054 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL29364667 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL13280 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL6750152 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL8166670 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL1903290 0.98 TSHR (1.00) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL10918562 0.96 TSHR (0.96) TSHRNFKB1MAPTKMT2AKDM4E
Dyrene SCHEMBL5745643 0.96 TSHR (0.96) TSHRNFKB1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117777473-A Triazine hydrogen bond organic framework material and metalate thereof, and preparation method and application thereof 浙江工业大学 2024-03-29 — — CN claimed
CN-117777473-A Triazine hydrogen bond organic framework material and metalate thereof, and preparation method and application thereof 浙江工业大学 2024-03-29 — — CN disclosed
CN-117777473-A Triazine hydrogen bond organic framework material and metalate thereof, and preparation method and application thereof 浙江工业大学 2024-03-29 — — CN disclosed
US-20220282044-A1 Polymerized high-molecular-weight sterically hindered amine and preparation method thereof BEIJING TIANGANG AUXILIARY CO., LTD. (CN) 2022-09-08 — — US disclosed
CN-112126060-B Polymeric high-molecular steric hindrance amine and preparation method thereof 北京天罡助剂有限责任公司 2022-05-31 — — CN disclosed
EP-3992230-A1 POLYMERIC POLYMER STERICALLY HINDERED AMINE AND PREPARATION METHOD THEREFOR Beijin Tiangang Auxiliary Co., Ltd. (CN) 2022-05-04 — — EP disclosed
CN-112126060-A Polymeric high-molecular steric hindrance amine and preparation method thereof 北京天罡助剂有限责任公司 2020-12-25 — — CN disclosed
EP-2364768-B1 Method of scavenging hydrogen sulfide and/or mercaptans using triazines BAKER HUGHES INC (US) 2016-02-17 — — EP disclosed
US-8734637-B2 Method of scavenging hydrogen sulfide and/or mercaptans using triazines BAKER HUGHES INCORPORATED (US) 2014-05-27 — — US disclosed
US-20110220551-A1 Method of Scavenging Hydrogen Sulfide and/or Mercaptans Using Triazines BAKER HUGHES HOLDINGS LLC 2011-09-15 — — US disclosed
EP-2364768-A1 Method of scavenging hydrogen sulfide and/or mercaptans using triazines BAKER HUGHES INCORPORATED (US) 2011-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110220551-A1 Method of Scavenging Hydrogen Sulfide and/or Mercaptans Using Triazines TST, CTH, CBS TSHR 255/4885NFKB1 3288/4885MAPT 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback